Proteomic profiling of cancer biomarkers

Briefings in Functional Genomics & Proteomics
Hungyi ShauHelena R Chang

Abstract

Early detection and correct diagnosis are essential for effective treatment of cancer and patient survival. Complete sequencing of the human genome, and the genomes of other species, provides valuable tools for discerning the genetic abnormalities in cancer. However, differences between cancerous and normal cells reflect more than variations in genetic sequences and abundance of transcribed RNA. Many cancer biomarkers are manifestation of differences in post-transcriptional splicing and/or post-translational modifications. Thus, proteomic tools are being increasingly utilised in the post-genomic era for discovery of new cancer biomarkers. In this paper we will provide an overview of the biomarker discovery process from the proteomic profiling point of view, with emphasis given to the principles that are involved in the process, including the protein identification strategies, and how surface enhanced laser desorption ionisation mass spectrometry fits into the picture. The aim is to provide a resource for the experimental practitioner seeking awareness of the analytical tools that are now available in contemporary cancer research.

Citations

Oct 12, 2012·Analytical and Bioanalytical Chemistry·J Giner Martínez-SierraJ I García Alonso
Jun 20, 2013·Journal of Assisted Reproduction and Genetics·Natalie A Clark, Jason E Swain
Dec 19, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rajeshwara N AchurKent E Vrana
Dec 3, 2005·Reproduction : the Official Journal of the Society for the Study of Fertility·Mandy G Katz-JaffeDavid K Gardner
Oct 20, 2006·Theriogenology·David K GardnerMark G Larman
Dec 13, 2005·Proteomics·Gyan BhanotArnold J Levine
Jun 15, 2007·Molecular Human Reproduction·Xiang MaJia-Yin Liu
Jun 21, 2011·Journal of Biomedicine & Biotechnology·Chibo Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.